Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 3286 AL 3300

The Role of Nutrition for the Aging Population: Implications for Cognition and Alzheimer's Disease

Power R, Prado-Cabrero A, Mulcahy R, Howard A, Nolan JM.

Annu Rev Food Sci Technol. 2019 Mar 25;10:619-639. doi: 10.1146/annurev-food-030216-030125.

[Caring for people suffering from Alzheimer's disease]

Chazot-Balcon M, Bouchard JP.

Rev Infirm. 2019 Jan;68(247):32-34. doi: 10.1016/j.revinf.2018.11.008.

Molecular mechanisms underlying protective role of quercetin in attenuating Alzheimer's disease

Zaplatic E, Bule M, Shah SZA, Uddin MS, Niaz K.

Life Sci. 2019 May 1;224:109-119. doi: 10.1016/j.lfs.2019.03.055. Epub 2019 Mar 23.

Current and Future Treatments in Alzheimer's Disease

Atri A.

Semin Neurol. 2019 Apr;39(2):227-240. doi: 10.1055/s-0039-1678581. Epub 2019 Mar 29.

Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis

Thancharoen O, Limwattananon C, Waleekhachonloet O, Rattanachotphanit T, Limwattananon P, Limpawattana P.

Drugs Aging. 2019 May;36(5):435-452. doi: 10.1007/s40266-019-00648-x.

Race reporting and disparities in clinical trials on Alzheimer's disease: A systematic review

Canevelli M, Bruno G, Grande G, Quarata F, Raganato R, Remiddi F, Valletta M, Zaccaria V, Vanacore N, Cesari M.

Neurosci Biobehav Rev. 2019 Jun;101:122-128. doi: 10.1016/j.neubiorev.2019.03.020. Epub 2019 Apr 1.

Pharmacokinetic Characterizations of Ginsenoside Ocotillol, RT5 and F11, the Promising Agents for Alzheimer's Disease from American Ginseng, in Rats and Beagle Dogs

Li Y, Hu H, Li Z, Li R, Xu F, Zhao C, An Y, Liu Y, Wang Z, Zhang B, Geng C.

Pharmacology. 2019;104(1-2):7-20. doi: 10.1159/000499595. Epub 2019 Apr 4.

Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer's disease

Dionisio-Santos DA, Olschowka JA, O'Banion MK.

J Neuroinflammation. 2019 Apr 5;16(1):74. doi: 10.1186/s12974-019-1453-0.

Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease

Ozben T, Ozben S.

Clin Biochem. 2019 Oct;72:87-89. doi: 10.1016/j.clinbiochem.2019.04.001. Epub 2019 Apr 4.

Histone Deacetylase Inhibitors as Multitarget Ligands: New Players in Alzheimer's Disease Drug Discovery?

De Simone A, Milelli A.

ChemMedChem. 2019 Jun 5;14(11):1067-1073. doi: 10.1002/cmdc.201900174. Epub 2019 May 2.

Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy

Tosi G, Pederzoli F, Belletti D, Vandelli MA, Forni F, Duskey JT, Ruozi B.

Prog Brain Res. 2019;245:57-88. doi: 10.1016/bs.pbr.2019.03.001. Epub 2019 Apr 2.

Monoamines and their Derivatives on GPCRs: Potential Therapy for Alzheimer's Disease

Farfán-García ED, Márquez-Gómez R, Barrón-González M, Pérez-Capistran T, Rosales-Hernández MC, Pinto-Almazán R, Soriano-Ursúa MA.

Curr Alzheimer Res. 2019;16(10):871-894. doi: 10.2174/1570159X17666190409144558.

Exercise as a potential modulator of inflammation in patients with Alzheimer's disease measured in cerebrospinal fluid and plasma

Jensen CS, Bahl JM, Østergaard LB, Høgh P, Wermuth L, Heslegrave A, Zetterberg H, Heegaard NHH, Hasselbalch SG, Simonsen AH.

Exp Gerontol. 2019 Jul 1;121:91-98. doi: 10.1016/j.exger.2019.04.003. Epub 2019 Apr 11.

Intravenous Immunoglobulin for Patients With Alzheimer's Disease: A Systematic Review and Meta-Analysis

Manolopoulos A, Andreadis P, Malandris K, Avgerinos I, Karagiannis T, Kapogiannis D, Tsolaki M, Tsapas A, Bekiari E.

Am J Alzheimers Dis Other Demen. 2019 Aug;34(5):281-289. doi: 10.1177/1533317519843720. Epub 2019 Apr 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias